Kazakhstan - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Kazakhstan Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases decreased by 2.9% year on year. In 2019, the country was number 15 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 5,073 Cases. Kazakhstan is overtaken by Indonesia, which was number 14 at 5,090 Cases and is followed by Kazakhstan at 4,930 Cases. India ranked the highest with 66,255 Cases in 2019, +13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 5,073.00 |
| 2018 | 4,869.00 |
| 2017 | 5,382.00 |
| 2016 | 5,817.00 |
| 2015 | 6,497.00 |
How does Kazakhstan rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 11 |
#11
Ukraine
|
7,405 | 2019 | +0.5 % | -0.9 % | View data | |
| 15 |
#15
Kazakhstan
|
5,073 | 2019 | +4.2 % | -2.9 % | View data | |
| 17 |
#17
Pakistan
|
3,925 | 2019 | +5.6 % | +3.9 % | View data | |